Results 91 to 100 of about 147,528 (279)

Defining Core Concepts for Health‐Related Quality of Life for Patients With Mycosis Fungoides and Sézary Syndrome: A Systematic Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background There is no consensus on how best to assess the impact of living with mycosis fungoides (MF)/Sézary syndrome (SS) on a patient's quality of life. Objectives To identify all potential concepts that describe disease severity or contribute to health‐related quality of life (HRQOL) from patients with MF/SS and their care partners ...
Christina Asare   +13 more
wiley   +1 more source

Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma.

open access: yesBlood, 2015
TOX is a nuclear factor essential for the development of CD4(+) T cells in the thymus. It is normally expressed in low amounts in mature CD4(+) T cells of the skin and the peripheral blood.
Yuanshen Huang   +3 more
semanticscholar   +1 more source

Mycosis Fungoides in Paediatric Patients: A Real‐Life Retrospective Study

open access: yesJEADV Clinical Practice, EarlyView.
Our study represents the largest cohort of children with MF worldwide, providing relevant evidence supporting phototherapy as first‐line treatment, with an overall remission rate of 36.36%. Both topical and systemic therapy also showed favourable outcomes.
Mariana de la Vega   +2 more
wiley   +1 more source

Prevalence, clinical features, and survival outcome trends of 627 patients with primary cutaneous lymphoma over 29 years: a retrospective review from single tertiary center in Korea

open access: yesScientific Reports
The relative frequency of primary cutaneous lymphoma (PCL) subtypes shows wide variation across different geographical regions. This retrospective study was conducted in a tertiary referral center located in Korea to describe the relative frequency ...
Ik Jun Moon   +7 more
doaj   +1 more source

Prevalence profile of cutaneous T- and B-cell lymphoma in Gharbia Governorate, Egypt

open access: yesJournal of the Egyptian Women’s Dermatologic Society
Background Lymphomas represent a heterogeneous group of lymphoid malignancies with varied patterns of clinical behavior and responses to treatment. The WHO classification distinguishes lymphoid neoplasms derived from precursor lymphoid cells from those ...
Nagwa M. Elwan   +3 more
doaj   +1 more source

Accessibility and readability of online patient education on cutaneous lymphomasCapsule Summary

open access: yesJAAD International, 2023
Background: Patients facing a cutaneous lymphoma diagnosis frequently turn to the internet for information but finding patient-accessible education may be a challenge.
Celine M. Schreidah, BS   +5 more
doaj  

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma

open access: yesHaematologica, 2015
The malignant mechanisms that control the development of cutaneous T-cell lymphoma (CTCL) are starting to be identified. Recent evidence suggests that disturbances in specific intracellular signaling pathways, such as RAS-MAPK, TCR-PLCG1-NFAT and JAK ...
C. Perez   +20 more
semanticscholar   +1 more source

Atypical Gamma‐Delta‐Positive T‐Cell Lymphoproliferation With Clinical Features of Lymphomatoid Papulosis in Three Children

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Primary cutaneous gamma‐delta T‐cell lymphoma has been described as an aggressive entity with a poor prognosis. However, gamma‐delta T‐cell receptor expression has been described in various types of skin lymphoproliferations. Paediatric cases of LyP are increasingly recognized, but paediatric LyP with a gamma‐delta phenotype have been rarely ...
Lachance Madeleine   +19 more
wiley   +1 more source

Parapsoriasis

open access: yesZdravniški Vestnik, 2014
Parapsoriasis is a dermatological term for a group of chronic erythematosquamous skin disorders, which share their clinical features and possibility of progression to cutaneous T-cell lymphoma.
Viktor Tenyi, Mateja Dolenc-Voljč
doaj  

Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma

open access: yesHaematologica, 2015
Resimmune is a second-generation recombinant immunotoxin composed of the catalytic and translocation domains of diphtheria toxin fused to two single chain antibody fragments reactive with the extracellular domain of CD3ε. We gave intravenous infusions of
A. Frankel   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy